Literature DB >> 16372166

[Residual neuromuscular blockades. Clinical consequences, frequency and avoidance strategies].

T Fuchs-Buder1, M Eikermann.   

Abstract

Even after administration in routine clinical dosages, muscle relaxants can lead to long-lasting residual blockades which increase the risk of severe postoperative pulmonary complications. Even without the additional effects from analgetics, sedatives or anaesthetics, a partial neuromuscular blockade, which cannot reliably be avoided either by the anaesthetist alone or by the additional use of nerve stimulators (train-of-four [TOF] ratio 0.5-0.9), can cause reductions in the vital capacity and the hypoxic breathing response, as well as obstruction of the upper airway and disruption of pharangeal function. The extent of neuromuscular recovery after an operation depends on the muscle relaxant used, the duration of administration, the anaesthetic technique and possible accompanying illnesses of the patient. It must basically be assumed that residual neuromuscular blockades are more frequent after administration of slow acting muscle relaxants such as pancuronium, than after the use of medium or rapid acting substances. If the course of a neuromuscular blockade is continually monitored during the whole anaesthetic procedure using the TOF ratio and not only occasionally at the end, a TOF ratio of 1 measured with an acceleromyograph (e.g. TOF-watch) promises an adequate neuromuscular recovery from the effects of muscle relaxants.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16372166     DOI: 10.1007/s00101-005-0959-2

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  45 in total

Review 1.  [The choice of stimulation patterns].

Authors:  N Schlaich; T Fuchs-Buder
Journal:  Anaesthesist       Date:  2000-04       Impact factor: 1.041

2.  Magnesium sulphate enhances residual neuromuscular block induced by vecuronium.

Authors:  T Fuchs-Buder; E Tassonyi
Journal:  Br J Anaesth       Date:  1996-04       Impact factor: 9.166

3.  Single acceleromyographic train-of-four, 100-Hertz tetanus or double-burst stimulation: which test performs better to detect residual paralysis?

Authors:  Amir Samet; Florent Capron; François Alla; Claude Meistelman; Thomas Fuchs-Buder
Journal:  Anesthesiology       Date:  2005-01       Impact factor: 7.892

4.  Relationship between chronic hypercapnia and inspiratory-muscle weakness in myotonic dystrophy.

Authors:  P Bégin; J Mathieu; J Almirall; A Grassino
Journal:  Am J Respir Crit Care Med       Date:  1997-07       Impact factor: 21.405

Review 5.  Antagonism of neuromuscular blockade.

Authors:  R D Miller
Journal:  Anesthesiology       Date:  1976-04       Impact factor: 7.892

6.  First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide.

Authors:  Francois Gijsenbergh; Steven Ramael; Natalie Houwing; Thijs van Iersel
Journal:  Anesthesiology       Date:  2005-10       Impact factor: 7.892

7.  Clinical concentrations of edrophonium enhance desensitization of the nicotinic acetylcholine receptor.

Authors:  C S Yost; E Maestrone
Journal:  Anesth Analg       Date:  1994-03       Impact factor: 5.108

8.  Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers.

Authors:  L I Eriksson; E Sundman; R Olsson; L Nilsson; H Witt; O Ekberg; R Kuylenstierna
Journal:  Anesthesiology       Date:  1997-11       Impact factor: 7.892

9.  Relationship between respiratory muscle strength and vital capacity during partial curarization in awake subjects.

Authors:  T J Gal; S K Goldberg
Journal:  Anesthesiology       Date:  1981-02       Impact factor: 7.892

10.  Multivariate determinants of early postoperative oxygen consumption in elderly patients. Effects of shivering, body temperature, and gender.

Authors:  S M Frank; L A Fleisher; K F Olson; R B Gorman; M S Higgins; M J Breslow; J V Sitzmann; C Beattie
Journal:  Anesthesiology       Date:  1995-08       Impact factor: 7.892

View more
  9 in total

Review 1.  [Neuromuscular blockades. Agents, monitoring and antagonism].

Authors:  J-U Schreiber; T Fuchs-Buder
Journal:  Anaesthesist       Date:  2006-11       Impact factor: 1.041

Review 2.  [Sugammadex. New pharmacological concept for antagonizing rocuronium and vecuronium].

Authors:  H J Sparr; L H Booij; T Fuchs-Buder
Journal:  Anaesthesist       Date:  2009-01       Impact factor: 1.041

3.  [Neuromuscular residual block : Unavoidable risk or reliably treatable?]

Authors:  T Fuchs-Buder
Journal:  Anaesthesist       Date:  2019-11       Impact factor: 1.041

Review 4.  [Neuromuscular monitoring in patients with neuromuscular diseases. Options and needs].

Authors:  A Beloiartsev; S Gableske; M Hübler
Journal:  Anaesthesist       Date:  2009-07       Impact factor: 1.041

5.  [Priming technique with cisatracurium Onset time at the laryngeal muscles].

Authors:  J Schmidt; S Albrecht; N Petterich; J Fechner; P Klein; A Irouschek
Journal:  Anaesthesist       Date:  2007-10       Impact factor: 1.041

Review 6.  [Perioperative risk and mortality after major surgery].

Authors:  O Boehm; M K A Pfeiffer; G Baumgarten; A Hoeft
Journal:  Anaesthesist       Date:  2015-11       Impact factor: 1.041

7.  Recovery and prediction of postoperative muscle power - is it still a problem?

Authors:  Martin Zoremba; Dennis Kornmann; Benjamin Vojnar; Rene Burchard; Thomas Wiesmann; Hinnerk Wulf; Thomas Kratz
Journal:  BMC Anesthesiol       Date:  2017-08-22       Impact factor: 2.217

8.  Comparison of the variability of the onset and recovery from neuromuscular blockade with cisatracurium versus rocuronium in elderly patients under total intravenous anesthesia.

Authors:  Feng Xiaobo; Ke Jianjuan; Wang Yanlin
Journal:  Braz J Med Biol Res       Date:  2012-05-17       Impact factor: 2.590

9.  The Effect of Patient Weight and Provider Training and Experience on Dosing of Rocuronium.

Authors:  N C Godwin; L Rodriguez; S Banks; B T Major; Y Rodriguez
Journal:  Anesthesiol Res Pract       Date:  2016-06-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.